Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1824293/000182429324000014/val-20240116.htm
May 2024
May 2024
April 2024
February 2024
January 2024
January 2024
January 2024
December 2023
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1824293/000182429324000014/val-20240116.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Gri Bio, Inc..
Gri Bio, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Gri Bio, Inc. provided additional information to their SEC Filing as exhibits
Ticker: GRIEvents:
CIK: 1824293
Form Type: 8-K Corporate News
Accession Number: 0001824293-24-000014
Submitted to the SEC: Tue Jan 16 2024 8:45:50 AM EST
Accepted by the SEC: Tue Jan 16 2024
Period: Tuesday, January 16, 2024
Industry: Pharmaceutical Preparations